DK6-16351-67817
3 vaccinations
12 coded responses
36 check-ins
8 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 283 / NC
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-26
Registered in v-safe
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fever · NoneAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-31
- 2021-04-03
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-05-01
-
2021-05-06
Survey response — day 42, single doseMedDRA: Asthma, Muscle spasms — Feeling: FairFree text: Muscle cramps, asthmaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-24
-
2021-11-03
Dose 2 — Moderna
-
2021-11-03
Survey response — day 0, dose 2MedDRA: Paraesthesia — Feeling: Fair · Site: PainFree text: Tingly feelingMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-19
- 2021-11-24
- 2021-12-03
- 2021-12-08
-
2021-12-15
Survey response — day 42, dose 2MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-12-15
Report sent to call center — day 42, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-21
-
2022-02-02
Survey response — 3 months, dose 2MedDRA: Chest pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Chest painsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Survey response — 6 months, dose 2MedDRA: Arthralgia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Shoulder painMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-09
- 2022-05-09
-
2022-12-17
Dose 3 — Pfizer-BioNTech
-
2022-12-22
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea, Sneezing — Feeling: FairFree text: Sneezing, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-24
-
2022-12-31
Survey response — day 14, dose 3MedDRA: Atrial fibrillation, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: I have had two recorded instances of atrial fibrillation. I have no prior heart disease or problems. · Healthcare visit (other): My doctor did not have appointments available and it is scheduled for a future date.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-31
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2023-01-03
- 2023-01-03
- 2023-01-03
- 2023-01-07
- 2023-01-14
- 2023-01-21
-
2023-01-28
Survey response — day 42, dose 3MedDRA: Chest discomfort, Dyspnoea — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-28
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-30
- 2023-01-30
- 2023-01-30
- 2023-01-30
-
2023-03-20
Survey response — 3 months, dose 3MedDRA: Chest discomfort, Respiratory disorder — Feeling: Poor · Be unable to work or attend schoolMedDRA releases: 2024-11
-
2023-06-17
Survey response — 6 months, dose 3MedDRA: Atrial fibrillation, Emergency care, Palpitations — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-03 | Moderna | No |
| 3 | 2022-12-17 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
Free text
Release 8 — day 42, single dose
Symptoms: Muscle cramps, asthma
Release 10 — day 0, dose 2
Systemic reaction (other): Tingly feeling
Release 10 — day 42, dose 2
Symptoms: Upper respiratory infection
Release 11 — 3 months, dose 2
Symptoms: Chest pains
Release 11 — 6 months, dose 2
Symptoms: Shoulder pain
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Runny nose, congestion
Systemic reaction (other): Sneezing, runny nose
Release 12 — day 14, dose 3
Symptoms: I have had two recorded instances of atrial fibrillation. I have no prior heart disease or problems.
Healthcare visit (other): My doctor did not have appointments available and it is scheduled for a future date.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Atrial fibrillation | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release